Clarient launches Clarient Insight Dx Pulmotype Test for lung cancer

[News]

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of a new lung cancer test, Clarient Insight® Dx Pulmotype® Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective.

More... (http://www.news-medical.net/news/20100210/Clarient-launches-Clarient-Insight-Dx-Pulmotype-Test-for-lung-cancer.aspx)